Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sitesT. P. Vassilakopoulos, Gerassimos A. Pangalis, Konstantinos Anargyrou et al.|European Journal Of Haematology|2001Cited by 37
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphomaTheodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Maria K. Angelopoulou et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 24
EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation is a Highly Effective Treatment Modality for Early Stage Hodgkin's DiseaseMaria K. Angelopoulou, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos et al.|Leukemia & lymphoma/Leukemia and lymphoma|2000Cited by 21
Fludarabine Monophosphate in Refractory B-Chronic Lymphocytic Leukemia: Maintenance may be Significant to Sustain ResponseMaria A. Angelopoulou, Gerassimos A. Pangalis, Christos Poziopoulos et al.|Leukemia & lymphoma/Leukemia and lymphoma|1996Cited by 17